400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Metabolic Enzyme / Aldose Reductase / Ranirestat
CAS No.: 147254-64-6
Synonyms: AS-3201;SX-3201
Ranirestat is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00927914 | Mild to Moderate Diabetic Sens... more >>orimotor Polyneuropathy. Collapse << | Phase 2 Phase 3 | Completed | - | United States, Maryland ... more >> The Johns Hopkins Hospital Baltimore, Maryland, United States, 21231 Collapse << |
NCT00101426 | Diabetic Neuropathy | Phase 3 | Completed | - | Canada, Ontario ... more >> Toronto General Hospital, University Health Network Toronto, Ontario, Canada, M5G 2C4 Collapse << |
实验方案
技术信息
CAS号 | 147254-64-6 | 储存条件 |
|
|
分子式 | C17H11BrFN3O4 | 运输 | 蓝冰 | |
分子量 | 420.19 | 别名 | AS-3201;SX-3201 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00927914 | Mild to Moderate Diabetic Sens... more >>orimotor Polyneuropathy. Collapse << | Phase 2 Phase 3 | Completed | - | United States, Maryland ... more >> The Johns Hopkins Hospital Baltimore, Maryland, United States, 21231 Collapse << |
NCT00101426 | Diabetic Neuropathy | Phase 3 | Completed | - | Canada, Ontario ... more >> Toronto General Hospital, University Health Network Toronto, Ontario, Canada, M5G 2C4 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网